Citation 121546

THOMPSON,WL: WANNEMACHER JR,RW:. (1986). STRUCTURE-FUNCTION RELATIONSHIPS OF 12,13-EPOXYTRICHOTHECENE MYCOTOXINS IN CELL CULTURE: COMPARISON TO WHOLE ANIMAL LETHALITY.. 24(10)

Citation Details

Title	STRUCTURE-FUNCTION RELATIONSHIPS OF 12,13-EPOXYTRICHOTHECENE MYCOTOXINS IN CELL CULTURE: COMPARISON TO WHOLE ANIMAL LETHALITY.
Authors	THOMPSON,WL: WANNEMACHER JR,RW:
Year	1986
Volume	24
Issue	10

Summary

Year: 1986

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	T-2 TOXIN	ACTIVE
2	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	T-2 TOXIN	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	T-2 TOXIN	ACTIVE
4	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	T-2 TOXIN	.
5	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	T-2 TOXIN	.
6	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HT-2 TOXIN	ACTIVE
7	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HT-2 TOXIN	ACTIVE
8	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HT-2 TOXIN	ACTIVE
9	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	HT-2 TOXIN	.
10	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	HT-2 TOXIN	.
11	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIOL,NEO:	ACTIVE
12	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIOL,NEO:	ACTIVE
13	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLANIOL,NEO:	ACTIVE
14	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	SOLANIOL,NEO:	.
15	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	SOLANIOL,NEO:	.
16	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERRUCAROL	ACTIVE
17	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERRUCAROL	ACTIVE
18	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCIRPENTRIOL	ACTIVE
19	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCIRPENTRIOL	ACTIVE
20	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSARENONE X	ACTIVE
21	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSARENONE X	ACTIVE
22	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSARENONE X	ACTIVE
23	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSARENONE X	.
24	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	FUSARENONE X	.
25	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIVALENOL	ACTIVE
26	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIVALENOL	ACTIVE
27	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIVALENOL	ACTIVE
28	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	NIVALENOL	.
29	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	NIVALENOL	.
30	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERRUCARIN A	ACTIVE
31	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERRUCARIN A	ACTIVE
32	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VERRUCARIN A	ACTIVE
33	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	VERRUCARIN A	.
34	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	VERRUCARIN A	.
35	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RORIDIN A	ACTIVE
36	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RORIDIN A	ACTIVE

Citation 121546

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1